Book your place on this new online interactive workshop now! Tuesday 19th October 11-12.30pm

Workshop title: “What’s in it for us?” An introduction to Public and Patient Involvement from the public’s perspective
Date: Tuesday 19th October, 11-12.30pm
Online
This new interactive RKEDF workshop explores how to develop meaningful engagement with the public. It is co-designed and facilitated by health advocates Rachel Jury and Tim Worner, who have both extensively shared their lived experience to the benefit of research studies, Dr Mel Hughes, academic lead of the BU PIER (Public Involvement in Education and Research) Partnership, and Angela Warren, PIER involvement coordinator.
The workshop provides an opportunity to learn about public involvement from the perspective of experts by experience, and to share and discuss ideas and plans.
You will:
- develop knowledge and understanding of different models of public involvement
- consider the benefits of public involvement for researchers and research users
- identify best practice in designing and conducting public involvement in research.
Researchers at any career stage or level are welcome – whether you are developing a public involvement strategy or just wish to find out more.
Book your place now
RKEDF Workshop: Introduction to Public and Patient Involvement
RKEDF Workshop: Public & Patient Involvement in Research – Tuesday 24 January 2-3:30pm










Join the 17th Annual Postgraduate Research Conference – Wednesday 3 December 2025
BU Festival of Social Sciences invite at RNLI
MaGPIE Presents at UK Parliament: From Mass Graves to Courtroom
Festival of Social Science: Introducing drowning prevention in Bangladesh
BU PhD student attending HIV conference on scholarship
ECR Funding Open Call: Research Culture & Community Grant – Apply Now
MSCA Postdoctoral Fellowships 2025 Call
ERC Advanced Grant 2025 Webinar
Horizon Europe Work Programme 2025 Published
Horizon Europe 2025 Work Programme pre-Published
Update on UKRO services
European research project exploring use of ‘virtual twins’ to better manage metabolic associated fatty liver disease